- Signal is a not-for-profit foundation with a messaging app.
- Signal Advance Inc. (SIGL) is a medical technology company with no messaging app.
- Investors mixed the two up and SIGL rose 5000%.
Signal Advance (SIGL) is a tiny medical technology company which was unheard of until last week. On January 4, not a single share traded in the stock market, a few days later the stock traded over 2 million shares! The daily average is less than 10,000.
The stock moved from $0.60 to nearly $40 in a matter of days.
SIGL stock: A case of mistaken identity
The reason for this extraordinary surge was due to a tweet sent out by Tesla (TSLA) CEO Elon Musk. He wanted people to switch from WhatsApp (FB) to Signal messaging app. Instead, people raced to snap up stock of Signal Advance (SIGL)!
Zoom (ZM) in, ZOOM out
Back in March 2020, at the start of the pandemic, the Securities and Exchange Commission (SEC) suspended trading of Zoom Technologies (ZOOM) as traders were buying it thinking it was ZOOM Video (ZM). ZOOM was up 900% when the SEC stepped in.
SIGL still going strong
Despite Signal Advance (SIGL) issuing a press release making people aware of the mistaken identity, SIGL is still trading much higher than its long-term average. SIGL closed on Friday at $13.54 down from near $40 earlier in the week. On January 6th it closed at $0.60!
The author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has received compensation for writing this article. The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice. It is important to do your own research before making any investment and take independent advice from a registered investment advisor. This article is for information purposes only. We/I do not provide personalized recommendations. I make no representations as to accuracy, completeness, the suitability of this information. I will not be liable for any errors, omissions or any losses, injuries or damages arising from this information display or use. I will not be held responsible for information that is found at the end of links posted on this page.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.